Demand for antidepressants, sleeping pills, and anti-anxiety medications surged after Russia's full-scale invasion of Ukraine. And it continues to grow.
In 2022, antidepressant sales amounted to 15 million packages, in 2021 – 11 million, in 2020 – 9,6 million, Vedomosti clarifies, citing data from DSM Group.
It is also known that in 2023, Russians spent 3,3 billion rubles on medications containing the active ingredient melatonin alone. This is a 10,3% increase over 2022 and the highest figure in the past five years.